The retina has emerged as a potential biomarker for the diagnosis of Alzheimer's Disease because decreased retinal thickness is evident in patients with known AD. This presentation proposes a research study that includes participants over the age of 65, with or without a diagnosis of AD. Participants' retinas would be imaged with optical coherence tomography, a quick and non-invasive imaging modality that produces high-resolution 3D images.